Literature DB >> 29289897

EGFR family and Src family kinase interactions: mechanics matters?

Zhongwen Chen1, Dongmyung Oh1, Alok Kumar Dubey1, Mingxi Yao1, Beverly Yang1, Jay T Groves2, Michael Sheetz3.   

Abstract

Receptor tyrosine kinases (RTKs), such as the EGF receptor family, and adhesion molecules, such as integrins, have historically been viewed to have distinctly separable roles in the cell. In this classical view, integrins mediate mechanical interactions between the cell and its surrounding extracellular matrix while RTKs handle signaling to modulate cellular behavior. Although crosstalk between these receptor pathways has been known to exist for a long time, this has generally been attributed to effects significantly downstream from the receptors themselves. In recent years, however, EGFR family RTKs have been found to directly participate in integrin-mediated force sensing, revealing a more complex interplay among these cellular components than originally appreciated. Here we briefly review the classical understanding of EGFR family RTK signaling and then provide a broadened perspective based on recent results.
Copyright © 2017. Published by Elsevier Ltd.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 29289897     DOI: 10.1016/j.ceb.2017.12.003

Source DB:  PubMed          Journal:  Curr Opin Cell Biol        ISSN: 0955-0674            Impact factor:   8.382


  19 in total

1.  Nanopore-mediated protein delivery enabling three-color single-molecule tracking in living cells.

Authors:  Zhongwen Chen; Yuhong Cao; Chun-Wei Lin; Steven Alvarez; Dongmyung Oh; Peidong Yang; Jay T Groves
Journal:  Proc Natl Acad Sci U S A       Date:  2021-02-02       Impact factor: 11.205

Review 2.  Comprehensive review of targeted therapy for colorectal cancer.

Authors:  Yuan-Hong Xie; Ying-Xuan Chen; Jing-Yuan Fang
Journal:  Signal Transduct Target Ther       Date:  2020-03-20

3.  Unraveling the Cellular Mechanism of Assembling Cholesterols for Selective Cancer Cell Death.

Authors:  Huaimin Wang; Zhaoqianqi Feng; Cuihong Yang; Jinjian Liu; Jamie E Medina; S Ali Aghvami; Daniela M Dinulescu; Jianfeng Liu; Seth Fraden; Bing Xu
Journal:  Mol Cancer Res       Date:  2018-12-14       Impact factor: 5.852

Review 4.  Context-dependent regulation of receptor tyrosine kinases: Insights from systems biology approaches.

Authors:  Inez Lam; Christina M Pickering; Feilim Mac Gabhann
Journal:  Wiley Interdiscip Rev Syst Biol Med       Date:  2018-09-26

Review 5.  Proliferative signaling by ERBB proteins and RAF/MEK/ERK effectors in polycystic kidney disease.

Authors:  Mitchell I Parker; Anna S Nikonova; Danlin Sun; Erica A Golemis
Journal:  Cell Signal       Date:  2019-12-09       Impact factor: 4.315

6.  Cell surface integrin α5ß1 clustering negatively regulates receptor tyrosine kinase signaling in colorectal cancer cells via glycogen synthase kinase 3.

Authors:  Alina Starchenko; Ramona Graves-Deal; Douglas Brubaker; Cunxi Li; Yuping Yang; Bhuminder Singh; Robert J Coffey; Douglas A Lauffenburger
Journal:  Integr Biol (Camb)       Date:  2021-06-15       Impact factor: 3.177

7.  Enigma proteins regulate YAP mechanotransduction.

Authors:  Ahmed Elbediwy; Hannah Vanyai; Maria-Del-Carmen Diaz-de-la-Loza; David Frith; Ambrosius P Snijders; Barry J Thompson
Journal:  J Cell Sci       Date:  2018-11-22       Impact factor: 5.285

Review 8.  Targeting the complexity of Src signalling in the tumour microenvironment of pancreatic cancer: from mechanism to therapy.

Authors:  Ashleigh Parkin; Jennifer Man; Paul Timpson; Marina Pajic
Journal:  FEBS J       Date:  2019-08-05       Impact factor: 5.542

9.  Simultaneously inactivating Src and AKT by saracatinib/capivasertib co-delivery nanoparticles to improve the efficacy of anti-Src therapy in head and neck squamous cell carcinoma.

Authors:  Liwei Lang; Chloe Shay; Xiangdong Zhao; Yuanping Xiong; Xuli Wang; Yong Teng
Journal:  J Hematol Oncol       Date:  2019-12-05       Impact factor: 17.388

Review 10.  The roles of integrins in cancer.

Authors:  Donatella Valdembri; Guido Serini
Journal:  Fac Rev       Date:  2021-05-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.